What is 3B Blackbio Dx Ltd (3BBLACKBIO) share price return in the past 10 years?

3B Blackbio Dx Ltd share price has appreciated 61% annually (CAGR) over the past ten years.

What is the share price of 3B Blackbio Dx Ltd (3BBLACKBIO)?

Company share prices are keep on changing according to the market conditions. The current trading price of 3B Blackbio Dx Ltd (3BBLACKBIO) on 05-Jun-2026 16:59:59 at 16:59 is 1121.05.

What is the P/E ratio of 3B Blackbio Dx?

The latest standalone P/E ratio of 3B Blackbio Dx as of 05-Jun-2026 is 19.66.

What is the P/B ratio of 3B Blackbio Dx Ltd (3BBLACKBIO)?

The latest standalone P/B ratio of 3B Blackbio Dx Ltd (3BBLACKBIO) as of 05-Jun-2026 is 3.55.

What is the 52-week high and low of 3B Blackbio Dx Ltd (3BBLACKBIO)?

The 52-week high of 3B Blackbio Dx Ltd (3BBLACKBIO) is Rs. 1750.00 and the 52-week low is Rs. 1083.50.

3B Blackbio Dx Ltd (3BBLACKBIO) Share Analysis – Quality, Pipeline & Valuation Zone & DeciZen Rating

Name: 3B Blackbio Dx Ltd (3BBLACKBIO)
Brand: 3B Blackbio Dx

3B Blackbio Dx Ltd (3BBLACKBIO)

Key Metrics

Valuation Multiples

Market Cap

₹970 Cr.

Current Price

₹1,121.1

52-Week Low / High

₹1,084 / 1,750

TTM EPS

₹57.5

TTM Sales

₹97.3 Cr.

Book Value per Share

₹317.9

P/E Ratio

19.66

Lower than its 5-year historical median

Industry PE

111.2

Price to Book (P/B)

3.55

Lower than its 5-year historical median

Price to Sales (P/S)

9.97

Lower than its 5-year historical median

EV/EBITDA

13.22

Lower than its 5-year historical median

Dividend Yield

0.25%

Profitability Efficiency

Return on Equity (ROE)

19.00%

Outperforms industry median

Return on Capital Employed (ROCE)

25.53%

Outperforms industry median

Return on Assets (ROA)

17.39%

Operating Profit Margin

55.1%

Net Profit Margin

52.53%

Gross Profit Margin

71.6%

Growth Momentum
1-yr vs 3-yr growth

Sales Growth (1 Year)

Slowing versus 3-year growth rate

28.01%

Operating Profit Growth (1 Year)

42.01%

Net Profit Growth (1 Year)

Slowing versus 3-year growth rate

39.02%

Asset Quality

Promoter Holding

40.94%

Pledged shares (%) of Promoter's holding (%)

0.00%

Reserves

₹264 Cr.

Equity

₹8.6 Cr.

Face Value

₹10

All Time Low / High

₹4.81 / 2350.00

3B Blackbio Dx stock performance

Key Ratios

Check Before You Invest

Quality

Somewhat Good

Check detailed performance

Valuation

Fair

Check Valuation charts

Price Trend

Weak

Check Price chart

Q.1 Is 3B Blackbio Dx Ltd a good quality company?

3B Blackbio Dx Ltd is a average quality company, based on a somewhat consistent multi-year financial track record.

This assessment is based on company’s performance on Revenue growth, ROCE, Equity and Assets, key margin ratios, cash conversion cycle, and debt to cash flow from operations and how it compares with its long term averages.

We have analysed the performance of the company on the following:

How has it performed on generating Profits?
By checking its Revenue growth, Gross, Operating and Net Margins compared to its last 5-year median.
How efficiently has it utilized Capital?
By checking its ROCE, ROA, ROE and its Cash Conversion Cycle.
How is it managing its Debt?
By checking its Debt to Equity and Cash Flow from Operations.

How does 3B Blackbio Dx Ltd performance compare with that of its Peers?

Q.1 Revenue growth of 3B Blackbio Dx Ltd vs industry peers?

3B Blackbio Dx Ltd revenue CAGR is 46.29%, compared to the industry median CAGR of 0%, indicating faster growth and gaining its market share.

Q.1 Promoter shareholding and pledge status of 3B Blackbio Dx Ltd?

Promoters hold 40.94% of the 3B Blackbio Dx Ltd, with 0.00% of their stake pledged, indicating no pledge risk.

Q.1 Stock return of 3B Blackbio Dx Ltd over the last decade?

Over the last 9 year(s), the stock has delivered a CAGR of 58.2% based on the current price.

10 Year X-Ray :

Analysis of Financial Track Record (Data adjusted to bonus, split, extra-ordinary income, rights issue and change in financial year end)

Data adjusted to bonus, split, extra-ordinary income, rights issue and change in financial year end

Value Creation ⓘ

	Mar'16	Mar'17	Mar'18	Mar'19	Mar'20	Mar'21	Mar'22	Mar'23	Mar'24	Mar'25	TTM
ROCE % ⓘ	4.8%	5.5%	6.1%	4.2%	4.1%	9.5%	33.5%	10.8%	36.6%	25.5%	-
Value Creation Index ⓘ	-0.7	-0.6	-0.6	-0.7	-0.7	-0.3	1.4	-0.2	1.6	0.8	-
Growth Parameters ⓘ
Sales ⓘ	15.7	13	15.6	12.1	13.5	14.4	15.5	12	70.7	90.5	97
Sales YoY Gr.	-	-17.1%	19.6%	-22.3%	11.8%	6.3%	8.1%	-22.7%	489.3%	28%	-
Adj EPS ⓘ	0.3	0.4	0.8	0.7	0.8	2.3	10.7	2.9	39.8	55.3	57.5
YoY Gr.	-	24.1%	125%	-17.3%	22.4%	179.3%	365.9%	-73%	1283.3%	38.7%	-
BVPS (₹) ⓘ	17.3	17.3	17.6	24.6	27.7	30.2	31.9	32.3	265.8	318.4	317.9
Adj Net Profit ⓘ	0.2	0.2	0.5	0.4	0.6	1.7	8	2.2	34.2	47.4	49
Cash Flow from Ops. ⓘ	0.9	0.2	-0.8	0.5	1.1	2.8	8	1.7	28.5	44.5	-
Debt/CF from Ops. ⓘ	8.5	33.4	-7.6	13.7	3.2	0.7	0.3	1.2	0	0	-

CAGR ⓘ

	9 Years	5 Years	3 Years	1 Years
Sales ⓘ	21.5%	46.3%	80%	28%
Adj EPS ⓘ	79.2%	132.1%	73%	38.7%
BVPSⓘ	38.2%	62.9%	115.2%	19.8%
Share Price	61%	21%	38.4%	-30.6%

Key Financial Parameters ⓘ

	Mar'16	Mar'17	Mar'18	Mar'19	Mar'20	Mar'21	Mar'22	Mar'23	Mar'24	Mar'25	TTM
Return on Equity % ⓘ	1.7	2.1	3.9	2.7	3.4	7.9	34.4	9	27.1	19	18.1
Op. Profit Mgn % ⓘ	6.6	8.2	7	3.6	-1.8	-8.4	-7.9	-7.8	49.6	55.1	54.7
Net Profit Mgn % ⓘ	1.2	1.8	3.3	3.6	4.5	12	51.6	18	48.4	52.4	50.7
Debt to Equity ⓘ	0.7	0.7	0.5	0.4	0.2	0.1	0.1	0.1	0	0	0
Working Cap Days ⓘ	445	529	488	665	597	549	521	686	214	246	233
Cash Conv. Cycle ⓘ	203	273	288	425	389	357	318	427	121	149	202

Profit And Loss

(All Figures are in Crores.)

PARTICULARS	Mar'16	Mar'17	Mar'18	Mar'19	Mar'20	Mar'21	Mar'22	Mar'23	Mar'24	Mar'25
Sales	16	13	16	12	14	14	16	12	71	91
Operating Expenses ⓘ +	15	12	14	12	14	16	17	13	36	41
Manufacturing Costs	2	8	0	0	0	0	0	0	1	1
Material Costs	8	0	10	9	10	11	12	9	20	24
Employee Cost	2	1	1	1	1	1	2	2	3	3
Other Costs ⓘ	3	3	2	2	2	3	3	2	11	12
Operating Profit ⓘ	1	1	1	0	-0	-1	-1	-1	35	50
Operating Profit Margin (%)	6.6%	8.2%	7.0%	3.6%	-1.8%	-8.4%	-7.9%	-7.8%	49.6%	55.1%
Other Income ⓘ +	0	0	0	1	1	4	10	4	12	15
Exceptional Items ⓘ	0	0	0	0	0	0	0	0	0	0
Interest ⓘ	1	1	1	0	0	0	0	0	0	0
Depreciation ⓘ	0	0	0	0	0	0	0	0	1	1
Profit Before Tax ⓘ	0	0	1	0	1	2	8	3	46	64
Tax ⓘ	0	0	0	0	0	0	0	0	12	16
Profit After Tax	0	0	1	0	1	2	8	2	34	48
PAT Margin (%)	1.2%	1.8%	3.3%	3.6%	4.5%	12.0%	51.6%	18.0%	48.4%	52.5%
Adjusted EPS (₹)	0.3	0.4	0.8	0.7	0.8	2.3	10.7	2.9	39.9	55.5
Dividend Payout Ratio (%)	0%	83.30%	61.40%	74.40%	85.40%	43.60%	98.20%	86.70%	7.50%	7.20%

Valuation of 3B Blackbio Dx - Standalone

YTD 1Y 3Y 5Y 10Y Max

Analyst's Notes

No data found!

Balance Sheet

(All Figures are in Crores.)

PARTICULARS	Mar'16	Mar'17	Mar'18	Mar'19	Mar'20	Mar'21	Mar'22	Mar'23	Mar'24	Mar'25
Equity and Liabilities
Shareholders Fund +	11	11	11	16	21	23	24	24	228	273
Share Capital ⓘ	6	6	6	6	7	7	7	7	9	9
Reserves ⓘ	5	5	5	9	13	15	16	17	219	264
Debt +	7	8	6	6	4	2	3	2	1	0
Long Term Debt	2	3	2	2	1	1	1	1	1	0
Short Term Debt	5	5	3	4	2	1	2	1	0	0
Minority Interest	0	0	0	0	0	0	0	0	0	0
Trade Payables	4	4	3	4	3	3	4	2	4	2
Others Liabilities ⓘ	1	1	6	1	1	1	2	1	18	22
Total Liabilities ⓘ	24	24	26	27	28	29	32	30	250	297
Fixed Assets
Net Fixed Assets ⓘ +	3	3	2	2	2	2	3	3	7	6
Gross Block	5	6	6	6	6	6	8	8	13	14
Accumulated Depreciation	3	3	3	4	4	4	4	5	6	7
CWIP ⓘ	0	0	0	0	0	0	0	0	0	0
Investments ⓘ	0	1	1	1	4	4	4	4	128	167
Inventories	3	3	3	4	3	3	3	3	8	8
Trade Receivables	13	13	14	14	14	14	14	14	36	35
Cash Equivalents	0	0	1	1	1	2	2	1	55	63
Others Assets ⓘ	5	4	4	4	4	5	6	6	16	18
Total Assets ⓘ	24	24	26	27	28	29	32	30	250	297

Cash Flow

(All Figures are in Crores.)

PARTICULARS	Mar'16	Mar'17	Mar'18	Mar'19	Mar'20	Mar'21	Mar'22	Mar'23	Mar'24	Mar'25
Cash Flow From Operating Activity ⓘ +	1	0	-1	0	1	3	8	2	28	44
PBT ⓘ	0	0	1	0	1	2	8	3	46	64
Adjustment ⓘ	1	1	1	1	1	0	0	1	-5	-5
Changes in Working Capital ⓘ	-0	-1	-2	-1	-0	1	-1	-1	-2	0
Tax Paid ⓘ	-0	-0	-0	-0	0	-0	-0	-1	-11	-15
Cash Flow From Investing Activity ⓘ +	-0	0	-0	-0	-2	-0	-2	-0	-20	-34
Capex	-0	-0	-0	-0	-0	-0	-2	-0	-1	-1
Net Investments	0	-0	-1	0	-2	0	0	0	-20	-33
Others ⓘ	0	1	1	0	-0	-0	-0	0	0	-0
Cash Flow From Financing Activity ⓘ +	-1	-0	1	-0	1	-2	-6	-3	-4	-3
Net Proceeds from Shares ⓘ	0	0	0	0	1	0	0	0	0	0
Net Proceeds from Borrowing ⓘ	0	0	0	0	0	0	0	0	0	0
Interest Paid ⓘ	-1	-1	-1	-0	-0	-0	-0	-0	-0	-0
Dividend Paid ⓘ	0	-0	-0	-0	-1	0	-7	-2	-2	-3
Others ⓘ	0	1	2	0	1	-1	1	-1	-1	-0
Net Cash Flow ⓘ	0	0	0	-0	0	1	0	-1	5	8

Financial Ratio

PARTICULARS	Mar'16	Mar'17	Mar'18	Mar'19	Mar'20	Mar'21	Mar'22	Mar'23	Mar'24	Mar'25
Ratios
ROE (%)	1.71	2.08	4.67	3.19	3.36	7.91	34.38	8.97	27.15	19
ROCE (%)	4.78	5.49	6.07	4.17	4.1	9.45	33.53	10.81	36.55	25.53
Asset Turnover Ratio	0.71	0.59	0.63	0.46	0.49	0.5	0.51	0.39	0.51	0.33
PAT to CFO Conversion(x)	N/A	N/A	-1	N/A	1	1.5	1	1	0.82	0.92
Working Capital Days
Receivable Days	279.30	337.10	316.70	426.90	381.80	359	334.30	426.60	129.50	144.40
Inventory Days	66.50	77.70	74.10	109.80	99.60	75.30	63.10	86.70	28.40	32.50
Payable Days	216.20	0	128.90	148.10	120.50	96.50	98.80	118.40	51.80	38.90

Management X-Ray

Shareholding Pattern

Promoter's Holding & Share Pledging

Pledged ^*

0.00

* Pledged shares as % of Promoter's holding (%)

Top 5 Mutual Funds Holding

Last Visited Stocks

Announcements

3B Blackbio Dx Ltd FAQs

The current trading price of 3B Blackbio Dx on 05-Jun-2026 16:59 is ₹1,121.1.

Market capitalization or market cap is determined by multiplying the current market price of a company's shares with the total number of shares outstanding. As of 04-Jun-2026 the market cap of 3B Blackbio Dx stood at ₹969.6 Cr

The latest P/E ratio of 3B Blackbio Dx as of 04-Jun-2026 is 19.66.

The latest P/B ratio of 3B Blackbio Dx as of 04-Jun-2026 is 3.55.

The 52-week high of 3B Blackbio Dx is ₹1,750 and the 52-week low is ₹1,083.5.

The TTM revenue is Trailing Twelve Months sales. The TTM revenue/sales of 3B Blackbio Dx is ₹97.28 ( Cr.) .

Past 10 year's financial track record analysis by Moneyworks4me indicates that 3B Blackbio Dx Ltd is a average quality company.

The key valuation ratios of 3B Blackbio Dx Ltd's currently when compared to its past seem to suggest it is in the Fair zone.

The Price Trend analysis by MoneyWorks4Me indicates it is Weak which suggest that the price of 3B Blackbio Dx Ltd is likely to Fall in the short term. However, please check the rating on Quality and Valuation before investing.

About 3B Blackbio Dx Ltd

Kilpest India is one of India's leading agri-based companies. Kilpest is an ISO certified company and has representation in India in the field of agriculture business comprising crop protection products and public health products, bio products, micro-nutrients and mix fertilizers. The company has one of the most advance Research & Development facility at its Bhopal plant and also has Biological Research Centre. The products are manufactured to high international! BlS specifications with stringent quality control from raw material procurement to finished goods despatch.

The products are manufactured to high international / BIS specifications with stringent quality control from raw material procurement to finished goods despatch. The company's manufacturing process is complimented with the technical expertise and it has attained high standard suited to customer needs.

The company has a nationwide distribution network. Kilpest is also doing toll formulations for multinational industries. Products of Kilpest are exported to several countries. The company is listed on the Bombay Stock Exchange. It is also registered with D&B, D-V-N-S.

Products range of the company includes:

Emulsifiable Concentrate
Wettable Powder/Soluble Powders
Garanules
Dusting Powder
Botanical Pesticides
Spray Adjuvant Cone
Flowering Stimulent / Yield Booster
Insecticide For Public Health
House Hold Insecticide
Sampada (Micro-Nutrients) / Fytozyme (Plant Growth Stimulant)

Clientele:

Directarate General of Supplies& Transport, New Delhi.
Directarate Health Services Haryana, Chandigarh.
Controller of Procurement, Material Organisation, Eastern Naval, Command, Visakhpatnam (NAVY).
Western Railway, Mumbai.
Central Railway, Mumbai.
Directorate of Central Medical Stores Organisation, Gujarat, Gandhi Nagar.
The Director General Medical Health and Family welfare, U. P. Lucknow.
Central Warehousing Corporation, Delhi.
Central Public Works Department, Kanpur & Bhopal.
Food Corporation of India, Bhopal, Lucknow, Mumbai, Jaipur.
Indian Farmers Fertilizer Co-operative Ltd. New Delhi.
M. P. State Co-operative Marketing Federation Ltd. Jehangirabad, Bhopal
Municipal Corporation, Bhopal/lndore, and many more

Achievements/ recognition:

An ISO certified company

3B Blackbio Dx Ltd (3BBLACKBIO)

3B Blackbio Dx Ltd (3BBLACKBIO)

3B Blackbio Dx stock performance

Check Before You Invest

Quality

Valuation

Price Trend

10 Year X-Ray :

Analysis of Financial Track Record (Data adjusted to bonus, split, extra-ordinary income, rights issue and change in financial year end)

Value Creation ⓘ

Growth Parameters ⓘ

CAGR ⓘ

Key Financial Parameters ⓘ

Profit And Loss

Valuation of 3B Blackbio Dx - Standalone

Price Calculator

Price Chart

Price to Earnings

Price to Sales

Price to Book

EV to EBITDA

Dividend History

Analyst's Notes

Balance Sheet

Equity and Liabilities

Fixed Assets

Cash Flow

Financial Ratio

Management X-Ray

Shareholding Pattern

Promoter's Holding & Share Pledging

Top 5 Mutual Funds Holding

Last Visited Stocks

Announcements

3B Blackbio Dx Ltd FAQs

About 3B Blackbio Dx Ltd

About MoneyWorks4Me

Our Vision

What Makes MoneyWorks4Me Different

Our Approach: Ensuring compounding work its magic on client portfolio.

Name of the IA registered with SEBI:	The Alchemists Ark Pvt. Ltd.
Logo:
Trade/Brand Name of IA:	MoneyWorks4Me Investment Advisers
Brand Logo:
SEBI Registration Number:	INA000013323 Validity – May 16, 2019 – Perpetual
Registration:	Non-Individual
BSE Enlistment No:	1187
Address:	B-101, Signet Corner Building, Balewadi Phata, Baner, Pune, Maharashtra 411045
Compliance officer Details:	Name: Shrikant Jagtap Email: shrikant.jagtap@moneyworks4me.com Telephone: +919860359463 Address: Same as IA
Grievance Officer Details:	Name: Mukta Vaze Email: mukta.vaze@moneyworks4me.com Telephone: +91 98609 19463 Address: Same as IA
Principal Officer Details:	Name: Atharva Bhide Email: atharva.bhide@moneyworks4me.com Telephone: +91 91758 99463 Address: Same as IA
Standard Warning:	Investment in securities market are subject to market risks. Read all the related documents carefully before investing.
Disclaimer:	Registration granted by SEBI, enlistment with exchange and certification from NISM in no way guarantee performance of the intermediary or provide any assurance of returns to investors.

3B Blackbio Dx Ltd (3BBLACKBIO)

3B Blackbio Dx Ltd (3BBLACKBIO)

3B Blackbio Dx stock performance

Check Before You Invest

Quality

Valuation

Price Trend

10 Year X-Ray :

Analysis of Financial Track Record (Data adjusted to bonus, split, extra-ordinary income, rights issue and change in financial year end)

Value Creation ⓘ

Growth Parameters ⓘ

CAGR ⓘ

Key Financial Parameters ⓘ

Profit And Loss

Valuation of 3B Blackbio Dx - Standalone

Price Calculator

Price Chart

Price to Earnings

Price to Sales

Price to Book

EV to EBITDA

Dividend History

Price Calculator

Price Chart

Price to Earnings

Enterprise Value to EBIT

Price to Book-Value

Price to Sales

Dividend History

Analyst's Notes

Balance Sheet

Equity and Liabilities

Fixed Assets

Cash Flow

Financial Ratio

Management X-Ray

Shareholding Pattern

Promoter's Holding & Share Pledging

Top 5 Mutual Funds Holding

Last Visited Stocks

Announcements

3B Blackbio Dx Ltd FAQs

What is the share price of 3B Blackbio Dx?

What is the market cap of 3B Blackbio Dx?

What is the P/E ratio of 3B Blackbio Dx?

What is the P/B ratio of 3B Blackbio Dx?

What is the 52-week high and low of 3B Blackbio Dx?

What is the TTM revenue of 3B Blackbio Dx?

Is 3B Blackbio Dx Ltd a good quality company?

Is 3B Blackbio Dx Ltd undervalued or overvalued?

Is 3B Blackbio Dx Ltd a good buy now?

About 3B Blackbio Dx Ltd

About MoneyWorks4Me

Our Vision

What Makes MoneyWorks4Me Different

Our Approach: Ensuring compounding work its magic on client portfolio.